首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
PREDICTION OF MOLECULAR BIOACTIVATION
摘要
<p>The present invention relates to methods for predicting molecular bioactivation, reactivity, and toxicity of compounds and their metabolites.</p>
申请公布号
EP2936358(A1)
申请公布日期
2015.10.28
申请号
EP20130818602
申请日期
2013.12.17
申请人
F.HOFFMANN-LA ROCHE AG
发明人
FORD, KEVIN, A.
分类号
G06F19/00
主分类号
G06F19/00
代理机构
代理人
主权项
地址
您可能感兴趣的专利
INTERVENTIONAL MEDICAL SYSTEMS, TOOLS, AND ASSOCIATED METHODS
Every day clothing integrated with sensory therapy and on board fidgets
SLEEP CONTROL DEVICE AND SLEEP CONTROL METHOD
FACIAL MASK AND METHOD OF MAKING
SYSTEMS AND METHODS FOR ADMINISTERING PULMONARY MEDICATIONS
IMPLANTABLE BLOOD PUMP
SUCTION CLEANING DEVICE
Acrylic Bone Cement Having a Delayed Release Polymerization Inhibitor such as an Anti-Oxidant For Increased Working Time
REMOVABLE INSERT CONTAINING SCENTED MATERIAL
METHOD OF TREATING CANCER
MODIFIED RELEASE OF 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL-1H-IMIDAZOL-1-YL)-3-(TRIFLOUOROMETHYL)PHENYL] BENZAMIDE SOLUBILIZED USING ORGANIC ACIDS
METHODS OF INDUCING AN IMMUNE RESPONSE WITH COMPOSITIONS COMPRISING A NEISSERIA MENINGITIDIS 741 PROTEIN
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
USE OF DEGARELIX IN THE TREATMENT OF ENDOMETRIOSIS AND RELATED DISEASES
PROBIOTIC COMPOSITION FOR ORAL HEALTH
In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs
USE OF CHROMIUM HISTIDINATE FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
Dosing and Administration of Oligonucleotide Cancer Therapies
METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT
